中国医院药学杂志2024,Vol.44Issue(7) :862-864.DOI:10.13286/j.1001-5213.2024.07.19

哌拉西林他唑巴坦联用莫西沙星致药物超敏反应综合征1例

Drug induced hypersensitivity syndrome caused by piperacillin tazobactam and moxifloxacin:one case report

何双成 唐丽丹
中国医院药学杂志2024,Vol.44Issue(7) :862-864.DOI:10.13286/j.1001-5213.2024.07.19

哌拉西林他唑巴坦联用莫西沙星致药物超敏反应综合征1例

Drug induced hypersensitivity syndrome caused by piperacillin tazobactam and moxifloxacin:one case report

何双成 1唐丽丹2
扫码查看

作者信息

  • 1. 江苏省血吸虫病防治研究所门诊部,江苏无锡 214064
  • 2. 南京医科大学附属常州第二人民医院药学部,江苏常州 213614
  • 折叠

摘要

药物超敏反应综合征是一种易被误诊误治且有致命风险的不良反应.该文报告了 1例联合应用哌拉西林他唑巴坦、莫西沙星10d后相继出现发热、皮疹、淋巴结肿大、肝功能异常等症状的患者.在停用所有治疗药物,予全身性糖皮质激素治疗后,患者好转.该例病例表明,患者用药后出现皮疹及全身不适症状,应考虑药物超敏反应综合征可能性并采取必要治疗措施.

Abstract

Drug-induced hypersensitivity syndrome(DIHS)is an under-recognized and potentially life-threatening hypersensitivity reaction.One patient successively presented with fever,rash,lymphadenopathy and elevated liver enzymes after a 10-day regimen of piperacillin tazobac-tam and moxifloxacin.Improvements occurred after a discon-tinuation of all previous medications and systemic corticoste-roid therapy.For patients presenting with skin rash and sys-temic abnormalities after medications,physicians should con-sider a possible diagnosis of DIHS and adopt aggressive measures.

关键词

哌拉西林/莫西沙星/超敏反应综合征/不良反应

Key words

piperacillin/moxifloxacin/drug-induced hypersensitivity syndrome/adverse reaction

引用本文复制引用

出版年

2024
中国医院药学杂志
中国药学会

中国医院药学杂志

CSTPCD北大核心
影响因子:1.198
ISSN:1001-5213
参考文献量18
段落导航相关论文